1 |
CE-VST01-JC
| 1件: CE-VST01-JC CE-VST01-JC | - | - | - | 1件: 25 25 |
2 |
Cidofovir
| 1件: Cidofovir Cidofovir | 1件: D00273
D00273
| - | - | 1件: 25 25 |
3 |
Cytarabine
| 1件: Cytarabine Cytarabine | 1件: D00168
D00168
| - | - | 7件: 11 11, 13, 14, 25, 49, 60, 65 |
4 |
Didanosine
| 1件: Didanosine Didanosine | 1件: D00296
D00296
| - | - | 2件: 25 25, 265 |
5 |
Efineptakin alfa
| 1件: NT-I7 NT-I7 | 1件: D11957
D11957
| - | - | 1件: 25 25 |
6 |
Emtricitabine
| 2件: Emtricitabine Emtricitabine; TRUVADA | 1件: D01199
D01199
| - | - | 4件: 25 25, 93, 265, 325 |
7 |
Enfuvirtide
| 1件: Enfuvirtide Enfuvirtide | 1件: D02499
D02499
| - | - | 2件: 25 25, 265 |
8 |
Filgrastim
| 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 35件: 2 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
9 |
Interferon alfa
| 1件: Interferon alfa Interferon alfa | 1件: D03305
D03305
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 6件: 13 13, 25, 26, 28, 56, 96 |
10 |
Interferon alfa-2b
| 2件: Interferon alfa-2b Interferon alfa-2b; Interferon alpha-2B | 1件: D02745
D02745
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 25 25, 34 |
11 |
Interleukin-7
| 2件: Interleukin-7 Interleukin-7; Recombinant human interleukin-7 | - | - | - | 1件: 25 25 |
12 |
Mefloquine
| 2件: Lariam Lariam; MEFLOQUINE | 1件: D04895
D04895
| - | - | 2件: 25 25, 46 |
13 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; Methylprednisolone acetate | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
14 |
Natalizumab
| 2件: Natalizumab Natalizumab; Tysabri | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 6件: 13 13, 15, 25, 46, 63, 96 |
15 |
Pembrolizumab
| 1件: Pembrolizumab Pembrolizumab | 1件: D10574
D10574
| 1件: PDCD1 PDCD1 💬 | 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 2件: 25 25, 285 |
16 |
Prednisolone
| 3件: Prednisolona Prednisolona; Prednisolone; Prednisolonum | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 42件: 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
17 |
Probenecid
| 1件: Probenecid Probenecid | 1件: D00475
D00475
| - | - | 1件: 25 25 |
18 |
Tenofovir
| 1件: Tenofovir Tenofovir | 1件: D06074
D06074
| - | - | 6件: 2 2, 13, 25, 93, 265, 325 |
19 |
Teriflunomide
| 2件: AUBAGIO AUBAGIO; Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 3件: 13 13, 25, 26 |
20 |
Topotecan
| 1件: Topotecan Topotecan | 1件: D08618
D08618
| 1件: TOP1 TOP1 💬 | - | 1件: 25 25 |
21 |
Zalcitabine
| 1件: Zalcitabine Zalcitabine | 1件: D00412
D00412
| - | - | 1件: 25 25 |
22 |
Zidovudine
| 3件: COMBIVIR COMBIVIR; Retrovir; Zidovudine | 1件: D00413
D00413
| - | - | 7件: 25 25, 26, 94, 135, 265, 325, 331 |